Want to track NRXP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NRX Pharmaceuticals Inc. (NRXP) Statistics
Valuation metrics
Market Cap 70.01M
Enterprise value 65.78M
Trailing P/E (ttm) -5.45
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) 31.21
Price/Book (mrq) -9.69
Enterprise Value/Revenue 28.69
Enterprise Value/EBITDA -2.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.02M
Average volume (90 days) 1.13M
Price summary
52-Week low 1.62
52-Week high 5.05
Beta -
50-Day moving average 3.13
200-Day moving average 2.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.7%
Operating margin -7.5%
Operational effectiveness
Return on assets -2.06%
Return on equity 1.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.21
Total debt (mrq) -
Total Debt/Equity (mrq) -0.07
Current ratio (mrq) 0.29%
Book value per share (mrq) -0.43
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
